Mitsubishi Tanabe Pharma

FTAY 
(FSE) 
 
9.500 <%= Resources.Global.txtDown %>
Updated 15/07/2019
Change % -1.55% Stock price decreasing
Change -0.15 Stock price decreasing
Volume 0
High 9.500
Low 9.500
Open 9.500
ISIN JP3469000008
Prev close 9.650
# of shares 561.42M
Market cap 5,333.47M EUR
Intraday

Market closed
Mitsubishi Tanabe Pharma
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  9.50 -4.5% Stock price decreasing -5.5% Stock price decreasing -17.9% Stock price decreasing -25.2% Stock price decreasing -34.6% Stock price decreasing
Powered by TradingView

Company profile

Mitsubishi Tanabe Pharma Corp is primarily engaged in the research and development, manufacturing, procurement, and sales of pharmaceuticals. The company functions through Pharmaceuticals segment which operates business activities related to ethical drugs and over-the-counter drugs. It offers the product such as, Kremezin, BindRen, Lexapro which are used for Diabetic nephropathy, chronic kidney diseases, hyperphosphatemia, and depression. Geographically, it operates through Japan and its business can be seen amplifying across the globe.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 July 2019 00:18:44
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB4 - 2019-07-17 01:18:44 - 2019-07-17 00:18:44 - 1000 - Website: OKAY